These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19398145)

  • 1. Quality of life in the actinic neoplasia syndrome: The VA Topical Tretinoin Chemoprevention (VATTC) Trial.
    Weinstock MA; Lee KC; Chren MM; Marcolivio K;
    J Am Acad Dermatol; 2009 Aug; 61(2):207-15. PubMed ID: 19398145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of increased actinic keratosis count on skin-related quality of life: results from the Veterans Affairs Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial.
    Beatson M; Siegel JA; Chren MM; Weinstock MA
    Eur J Dermatol; 2019 Oct; 29(5):507-510. PubMed ID: 31647464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments).
    Hasan ZU; Ahmed I; Matin RN; Homer V; Lear JT; Ismail F; Whitmarsh T; Green AC; Thomson J; Milligan A; Hogan S; Van-de-Velde V; Mitchell-Worsford L; Kentley J; Gaunt C; Jefferson-Hulme Y; Bowden SJ; Gaunt P; Wheatley K; Proby CM; Harwood CA
    Br J Dermatol; 2022 Sep; 187(3):324-337. PubMed ID: 34988975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability of counting actinic keratoses before and after brief consensus discussion: the VA topical tretinoin chemoprevention (VATTC) trial.
    Weinstock MA; Bingham SF; Cole GW; Eilers D; Naylor MF; Kalivas J; Taylor JR; Gladstone HB; Piacquadio DJ; DiGiovanna JJ
    Arch Dermatol; 2001 Aug; 137(8):1055-8. PubMed ID: 11493098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis: A Randomized Clinical Trial.
    Pomerantz H; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin G; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri J; Lew R; Weinstock MA;
    JAMA Dermatol; 2015 Sep; 151(9):952-60. PubMed ID: 25950503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of Keratinocyte Carcinomas and Patients with Keratinocyte Carcinomas Following a Single 2-4 Week Course of Topical 5-fluorouracil on the Face and Ears.
    Beatson M; Means AD; Leader NF; Robinson-Bostom L; Weinstock MA
    Acta Derm Venereol; 2019 Jun; 99(7):707-708. PubMed ID: 30896781
    [No Abstract]   [Full Text] [Related]  

  • 7. Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.
    Criscione VD; Weinstock MA; Naylor MF; Luque C; Eide MJ; Bingham SF;
    Cancer; 2009 Jun; 115(11):2523-30. PubMed ID: 19382202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
    Cunningham TJ; Tabacchi M; Eliane JP; Tuchayi SM; Manivasagam S; Mirzaalian H; Turkoz A; Kopan R; Schaffer A; Saavedra AP; Wallendorf M; Cornelius LA; Demehri S
    J Clin Invest; 2017 Jan; 127(1):106-116. PubMed ID: 27869649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective quality of life impact of actinic keratoses: observations from the veterans affairs topical tretinoin chemoprevention trial.
    Lee K; Weinstock M
    Acta Derm Venereol; 2011 Jan; 91(1):101-2. PubMed ID: 21103828
    [No Abstract]   [Full Text] [Related]  

  • 10. Tretinoin and the prevention of keratinocyte carcinoma (Basal and squamous cell carcinoma of the skin): a veterans affairs randomized chemoprevention trial.
    Weinstock MA; Bingham SF; Digiovanna JJ; Rizzo AE; Marcolivio K; Hall R; Eilers D; Naylor M; Kirsner R; Kalivas J; Cole G; Vertrees JE;
    J Invest Dermatol; 2012 Jun; 132(6):1583-90. PubMed ID: 22318383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical efficacy of topical methyl-aminolevulinate photodynamic therapy in moderate to severe actinic keratoses of the face and scalp.
    Kleinpenning MM; van de Kerkhof PC; Gerritsen RM
    J Dermatolog Treat; 2010 Jul; 21(4):252-7. PubMed ID: 19832288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keratinocyte Carcinoma Chemoprevention With a Combination of Imiquimod, 5-Fluorouracil, and Tretinoin.
    Nahm W; Nichols A; Rapoport E; Kirsner R; Badiavas E; Wyant W; Arthur A; Shen J
    J Drugs Dermatol; 2023 May; 22(5):486-490. PubMed ID: 37133482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of squamous cell carcinoma in high-risk patients in the VATTC trial.
    Xiong MY; Rizzo AE; Cohen TS; Dyer RK; Korgavkar K; Bingham SF; Weinstock MA;
    J Invest Dermatol; 2013 Jun; 133(6):1521-32. PubMed ID: 23348836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability of high-dose topical tretinoin: the Veterans Affairs Topical Tretinoin Chemoprevention Trial.
    Geng A; Weinstock MA; Hall R; Eilers D; Naylor M; Kalivas J;
    Br J Dermatol; 2009 Oct; 161(4):918-24. PubMed ID: 19681859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Fluorouracil for Actinic Keratosis Treatment and Chemoprevention: A Randomized Controlled Trial.
    Walker JL; Siegel JA; Sachar M; Pomerantz H; Chen SC; Swetter SM; Dellavalle RP; Stricklin GP; Qureshi AA; DiGiovanna JJ; Weinstock MA
    J Invest Dermatol; 2017 Jun; 137(6):1367-1370. PubMed ID: 28532759
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial.
    Weinstock MA; Thwin SS; Siegel JA; Marcolivio K; Means AD; Leader NF; Shaw FM; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin GP; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri JE; Robinson-Bostom L; Ringer RJ; Lew RA; Ferguson R; DiGiovanna JJ; Huang GD;
    JAMA Dermatol; 2018 Feb; 154(2):167-174. PubMed ID: 29299592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation and comparison of quality-of-life measures for topical 5-fluorouracil treatment: results from a randomized controlled trial.
    Pomerantz H; Chren MM; Lew R; Weinstock MA;
    Clin Exp Dermatol; 2017 Jul; 42(5):488-495. PubMed ID: 28621489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical Tretinoin Chemoprevention) trial.
    Dyer RK; Weinstock MA; Cohen TS; Rizzo AE; Bingham SF;
    J Invest Dermatol; 2012 Nov; 132(11):2544-51. PubMed ID: 22810303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of topical fluorouracil cream on costs of treating keratinocyte carcinoma (nonmelanoma skin cancer) and actinic keratosis.
    Yoon J; Phibbs CS; Chow A; Weinstock MA;
    J Am Acad Dermatol; 2018 Sep; 79(3):501-507.e2. PubMed ID: 29505863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ingenol mebutate as topical treatment for actinic keratosis based on a prospective, non-interventional, multicentre study of real-life clinical practice in Germany: efficacy and quality of life.
    Diepgen TL; Eicke C; Bastian M
    Eur J Dermatol; 2019 Aug; 29(4):401-408. PubMed ID: 31625920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.